Molecular Genetics and Metabolism
Издатель: Elsevier · ISSN 1096-7192 · 48 статей
- Early hyperkinetic movement disorders and genotype–phenotype correlations in ACO2-related infantile cerebellar–retinal degeneration: two new patients and a systematic analysis of 42 published cases
- Nicotinamide riboside improves clinical performance in methionyl-tRNA formyltransferase deficiency
- Clinical and molecular characterisation of m.3243A>G-associated diabetes among young-onset diabetes in a multi-ethnic Asian population
- Overview of human heme biosynthesis: regulatory mechanisms and their link to porphyrias
- A systems-level model of diagnostic delay and failure in rare genetic disease: evidence from congenital disorders of glycosylation1
- Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuria
- Genetic Metabolic Dietitians International
- A practical diagnostic guide for the Porphyrias: Reducing misdiagnosis through phenotype-driven testing
- Cover 2 / Ed. Board
- Predicted deficiency of the GTP cyclohydrolase I feedback regulatory protein (GFRP): a disorder of dynamic tetrahydrobiopterin homeostasis
- Gallbladder involvement in metachromatic leukodystrophy: a systematic review and comparison of American and European surveillance recommendations
- CRISPR screening in neurodegeneration and lysosomal biology: Uncovering disease mechanisms and genetic modifiers
- Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review
- Breastfeeding infants with inherited metabolic disorders: review of current strategies and practical recommendations to overcome challenges
- Current management of biotinidase deficiency following newborn screening in Italy: evidence from a clinical nationwide survey
- FGF21 elevation is a biomarker of citrin deficiency and its metabolic dysregulation in pediatric patients
- Muscle ATP homeostasis and exercise: insights from ADSS1 myopathy
- Longitudinal audiological findings in mild to moderate Mucopolysaccharidosis type II and potential impact of inner ear dysfunction following blood-brain barrier-penetrating enzyme therapy
- Clinical, biochemical, and genetic perspectives in hepatic glycogen storage diseases: HEPA-GSD study
- Clinical characteristics and management of patients with mucopolysaccharidosis II in the United States enrolled in the Hunter Outcome Survey
- A quantitative disorder–phenotype atlas of inherited metabolic disorders reveals shared symptom spaces and group-specific hotspots
- A prospective, longitudinal, natural history study of neurological disease trajectory in children with late-infantile or juvenile-onset GM1 gangliosidosis or GM2 gangliosidoses: the PRONTO study
- Phosphodiesterase-5 inhibition as an off-label therapy in mitochondrial disease
- C-type lectin 10A [CD301] mRNA is upregulated in symptomatic acute intermittent porphyria and decreases after heme treatment
- Single-center real-world experience with givosiran for management of acute intermittent porphyria
- Empowering children and young people with Erythropoietic Protoporphyria (EPP)/X-linked Erythropoietic Protoporphyria (XLP): Outcomes of attending a disease-specific residential camp
- Intravenous hemin for prevention of frequent attacks of acute hepatic porphyria - a double-blind placebo controlled pilot study
- Masculinizing hormone therapy in latent AIP. First case in Argentina
- Porphyria cutanea tarda: cutaneous manifestations and management
- The burden of an ultra-rare inherited skin disorder: Congenital erythropoietic porphyria